$599
BremelanotideFDA-approvedWhat it's for
FDA-approved melanocortin medicine for low sexual desire with distress in premenopausal women (Vyleesi).
DrPepAI
16 cards in this region— educational names only, not recommendations or dosing.
$599
BremelanotideFDA-approvedFDA-approved melanocortin medicine for low sexual desire with distress in premenopausal women (Vyleesi).
Porcine brain peptide mixture — not FDA-approved in the U.S.
Investigational — tiny support rods inside nerve cells-stabilizing peptide (NAP); not approved.
$349
SemaglutideFDA-approved (prescription brands include Ozempic® and Wegovy®)FDA-approved GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Ozempic / Wegovy / Rybelsus (each brand has its own approved uses).
$499
TirzepatideFDA-approved (prescription brands include Mounjaro® and Zepbound®)FDA-approved dual GIP/GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Mounjaro / Zepbound (label-specific).
Historical GPE/trofinetide development context — not a separate approved drug.
delivered into the fluid around the spinal cord N-type calcium channel blocker for severe chronic pain (Prialt).
Cosmetic ingredient (Argireline) — not an FDA-approved drug.
Cosmetic ingredient (SNAP-8) — not an FDA-approved drug.
Cosmetic ingredient (eyeseryl-type peptide) — not an FDA-approved drug.
FDA-approved (Scenesse) for erythropoietic protoporphyria — not a beauty tan.
Polypeptide antibiotic — topical first-aid and selected systemic historical uses.
Cosmetic ingredient (GHK-Cu INCI name) — not an FDA-approved drug.
Long-acting lipoglycopeptides for serious gram-positive/skin infections.
IV (into a vein) cyclic lipopeptide for complicated skin infections and bacteremia/endocarditis (labeled uses).
FDA-approved peripheral kappa medicines that activate their target pathway for dialysis-associated itch (Korsuva).
Cosmetic ingredient (Syn-Ake) — not an FDA-approved drug.
FDA-approved kallikrein inhibitor for acute HAE (hereditary angioedema, dangerous swelling attacks) attacks (Kalbitor).
$39
GlutathioneNot FDA-approved · Investigational / research chemicalNatural antioxidant peptide — common in wellness talk; many claims exceed solid drug-level evidence.
Cosmetic ingredient (collagen-fragment signal peptide) — not an FDA-approved drug.
Research pigment peptide — not an FDA-approved consumer tanning drug.
$42
Melanotan IINot FDA-approved · Investigational / research chemicalUnapproved tanning/research melanocortin peptide — not FDA-approved.
Cosmetic ingredient (melanostatine-type peptide) — not an FDA-approved drug.
Cosmetic ingredient (EGF-related oligopeptide) — not an FDA-approved drug.
Cosmetic ingredient (elastin-signal peptide) — not an FDA-approved drug.
Cosmetic ingredient (Matrixyl) — not an FDA-approved drug.
Cosmetic ingredient (Matrixyl 3000 component) — not an FDA-approved drug.
Cosmetic ingredient (Matrixyl 3000 component) — not an FDA-approved drug.
Cosmetic ingredient (Matrixyl Synthe’6) — not an FDA-approved drug.
Cosmetic ingredient (Leuphasyl) — not an FDA-approved drug.
Cosmetic ingredient (decorinyl-type peptide) — not an FDA-approved drug.
Research metabolism compound — not FDA-approved.
Investigational — GLP-2 analog for SBS — not approved.
Investigational — defensin-mimetic antibiotic — not approved.
Clinical-stage amylin-pathway weight peptide — not FDA-approved alone.
FDA-approved ready-to-use glucagon analog for severe hypoglycemia (Zegalogue).
Investigational — oral PCSK9 peptide (enlicitide) — not approved.
HGH-fragment research peptide — not FDA-approved.
FDA-approved PET imaging agent for somatostatin-receptor–positive NETs (Netspot).
Investigational — GLP-2 analog (glepaglutide) — not approved.
FDA-approved depot somatostatin analog (Somatuline Depot).
Investigational — celiac adjunct peptide — not approved.
FDA-approved GC-C medicines that activate their target pathway for IBS-C and CIC (Linzess).
$399
LiraglutideFDA-approvedFDA-approved daily GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Victoza / Saxenda.
FDA-approved Lu-177 DOTATATE radioligand therapy (Lutathera).
FDA-approved somatostatin analog — Sandostatin / LAR (long-acting release) / Mycapssa.
In clinical trials for weight and liver-fat research — not yet FDA-approved.
Investigational — amylin analog (petrelintide) — not approved.
FDA-approved GC-C medicines that activate their target pathway (Trulance) for CIC and IBS-C.
$79
RetatrutideIn clinical trials · Not yet FDA-approvedIn clinical trials for obesity — not yet FDA-approved.
$349
SemaglutideFDA-approved (prescription brands include Ozempic® and Wegovy®)FDA-approved GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Ozempic / Wegovy / Rybelsus (each brand has its own approved uses).
FDA-approved MC4R (a brain melanocortin pathway tied to appetite and energy) medicines that activate their target pathway for rare genetic obesities (Imcivree).
Investigational — dual medicines that activate their target pathway (survodutide) — not approved.
FDA-approved terlipressin for HRS (hepatorenal syndrome, kidney failure linked to liver disease).
$699
TesamorelinFDA-approvedFDA-approved GHRH (growth-hormone–releasing hormone, a brain signal that asks the pituitary to release growth hormone) analog for HIV lipodystrophy visceral fat (Egrifta).
$499
TirzepatideFDA-approved (prescription brands include Mounjaro® and Zepbound®)FDA-approved dual GIP/GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Mounjaro / Zepbound (label-specific).
FDA-approved immunosuppressant ring-shaped peptide (Neoral/Sandimmune/Restasis contexts).
Investigational antibiotic aimed at Pseudomonas — not FDA-approved.
Investigational — sepsis immunomodulator peptide — not approved.
Last-line polymyxin antibiotics for MDR gram-negatives.
Thymalfasin / Ta1 — not FDA-approved for general U.S. use.
Previously FDA-approved weekly GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine (Tanzeum); market discontinued.
FDA-approved ACTH (the pituitary signal that tells the adrenals to make cortisol) repository gel for selected indications.
FDA-approved ACTH (the pituitary signal that tells the adrenals to make cortisol) stim test agent (Cortrosyn).
FDA-approved weekly GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine (Trulicity).
Investigational — GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — not FDA-approved/marketed.
Investigational — mitochondrial peptide — not approved.
FDA-approved insulin analogs — foundational diabetes therapy.
$55
IpamorelinNot FDA-approved · Investigational / research chemicalResearch growth hormone-release peptide — not FDA-approved.
FDA-approved daily GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine (Adlyxin).
FDA-approved lab-made human IGF-1 for severe primary IGF-1 deficiency (Increlex).
FDA-approved pasireotide for Cushing’s disease / acromegaly (Signifor).
FDA-approved growth hormone medicine that blocks a receptor signal (Somavert).
$349
SemaglutideFDA-approved (prescription brands include Ozempic® and Wegovy®)FDA-approved GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Ozempic / Wegovy / Rybelsus (each brand has its own approved uses).
FDA-approved daily lab-made human growth hormone (multiple brands).
Brand tesamorelin (Egrifta) is FDA-approved for a specific HIV lipodystrophy use; compounded versions are different.
$499
TirzepatideFDA-approved (prescription brands include Mounjaro® and Zepbound®)FDA-approved dual GIP/GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Mounjaro / Zepbound (label-specific).
FDA-approved salmon calcitonin — specialty/limited osteoporosis role.
Unapproved myostatin-pathway research agent — not FDA-approved.
$55
IpamorelinNot FDA-approved · Investigational / research chemicalResearch growth hormone-release peptide — not FDA-approved.
Muscle IGF-1 splice research peptide — not FDA-approved.
Not a peptide — oral growth-hormone release-nudge (secretagogue) -R medicines that activate their target pathway; not FDA-approved.
FDA-approved once-daily PTH (parathyroid hormone, which manages calcium) prodrug for hypoparathyroidism (Yorvipath).
FDA-approved rhPTH(1-84) for hypoparathyroidism (Natpara) — check supply status.
$54
SermorelinNot FDA-approved · Investigational / research chemicalGHRH (growth-hormone–releasing hormone, a brain signal that asks the pituitary to release growth hormone)-fragment peptide — not a casual anti-aging FDA wellness drug.
FDA-approved bone anabolic PTH (parathyroid hormone, which manages calcium).
Repair-biology peptide — research/clinical contexts vary; not a general OTC recovery drug.
FDA-approved under-the-skin C5 inhibitor for gMG (Zilbrysq).
FDA-approved IV (into a vein) angiotensin II for shock (Giapreza).
Investigational — CXCR4 medicines that block a signal — not approved.
FDA-approved IV (into a vein) DTI for PCI (a heart artery procedure).
FDA-approved desmopressin (DDAVP) for diabetes insipidus (a water-balance condition), enuresis, and selected bleeding uses.
FDA-approved platelet surface receptors called GPIIb/IIIa (needed for clumping) inhibitor (Integrilin).
FDA-approved CXCR4 medicines that block a signal for stem-cell mobilization (Aphexda).
FDA-approved recombinant BNP (Natrecor) — niche/historical ADHF use.
Investigational — hepcidin mimetic for PV — not approved.
Investigational — selective V1a medicines that activate their target pathway — not approved.
$349
SemaglutideFDA-approved (prescription brands include Ozempic® and Wegovy®)FDA-approved GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Ozempic / Wegovy / Rybelsus (each brand has its own approved uses).
$499
TirzepatideFDA-approved (prescription brands include Mounjaro® and Zepbound®)FDA-approved dual GIP/GLP-1 (a gut hormone signal for fullness and blood-sugar handling) medicine — Mounjaro / Zepbound (label-specific).
FDA-approved vasopressin for shock (Vasostrict) and related uses.
FDA-approved GnRH (the brain's master reproductive-hormone signal) medicines that block a signal for ART (Cetrotide).
GnRH (the brain's master reproductive-hormone signal) peptide — clinical/diagnostic contexts; compounded wellness use is not an FDA lifestyle approval.
FDA-approved hCG products for fertility/selected endocrine uses.
Research kisspeptin fragment — not FDA-approved.
FDA-approved GnRH (the brain's master reproductive-hormone signal) depot medicine — multiple labeled hormone uses.
FDA-approved Lu-177 PSMA therapy (Pluvicto).
FDA-approved GnRH (the brain's master reproductive-hormone signal) depot medicine — labeled hormone uses.
Merch perk
Drop your email for a 10% apparel merch code. Educational content stays free — this offer is for tees only, never peptides.
You’re in — watch your inbox for the code.